LEADER 01565oam  2200409 a 450 
001 9910697017203321
005 20230902161641.0
035   $a(CKB)5470000002384733
035   $a(OCoLC)607941691
035   $a(EXLCZ)995470000002384733
100   $a20100419d2010      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aFood and Drug Administration$b[electronic resource] $eimproved monitoring and development of performance measures needed to strengthen oversight of criminal and misconduct investigations : report to the Ranking Member, Committee on Finance, U.S. Senate
210  1$a[Washington, D.C.] :$cU.S. Govt. Accountability Office,$d[2010]
215   $a1 online resource (ii, 38 pages) $cillustrations
300   $aTitle from PDF title screen (GAO, viewed Apr. 19, 2010).
300   $a"January 2010."
300   $a"GAO-10-221."
320   $aIncludes bibliographical references.
517   $aFood and Drug Administration 
606   $aCriminal investigation$zUnited States
606   $aGovernmental investigations$zUnited States
607   $aUnited States$xOfficials and employees$xDiscipline
615  0$aCriminal investigation
615  0$aGovernmental investigations
712 02$aUnited States.$bCongress.$bSenate.$bCommittee on Finance.
801  0$bVVK
801  1$bVVK
801  2$bGPO
906   $aBOOK
912   $a9910697017203321
996   $aFood and Drug Administration$93425941
997   $aUNINA